Publications
Journal Articles
Akgül, Seçkin, Offenhäuser, Carolin, Kordowski, Anja and Day, Bryan W. (2022). Engineering novel lentiviral vectors for labelling tumour cells and oncogenic proteins. Bioengineering, 9 (3) 91. doi: 10.3390/bioengineering9030091
Müller Bark, Juliana, Kulasinghe, Arutha, Hartel, Gunter, Leo, Paul, Warkiani, Majid Ebrahimi, Jeffree, Rosalind L., Chua, Benjamin, Day, Bryan W. and Punyadeera, Chamindie (2021). Isolation of circulating tumour cells in patients with glioblastoma using spiral microfluidic technology – a pilot study. Frontiers in Oncology, 11 681130, 681130. doi: 10.3389/fonc.2021.681130
Lenin, Sakthi, Ponthier, Elise, Scheer, Kaitlin G., Yeo, Erica C. F., Tea, Melinda N., Ebert, Lisa M., Mansilla, Mariana Oksdath, Poonnoose, Santosh, Baumgartner, Ulrich, Day, Bryan W., Ormsby, Rebecca J., Pitson, Stuart M. and Gomez, Guillermo A. (2021). A drug screening pipeline using 2D and 3D patient-derived in vitro models for pre-clinical analysis of therapy response in glioblastoma. International Journal of Molecular Sciences, 22 (9) 4322, 1-27. doi: 10.3390/ijms22094322
Lim, Yi Chieh, Ensbey, Kathleen S., Offenhäuser, Carolin, D'souza, Rochelle C. J., Cullen, Jason K., Stringer, Brett W., Quek, Hazel, Bruce, Zara C., Kijas, Amanda, Cianfanelli, Valentina, Mahboubi, Bijan, Smith, Fiona, Jeffree, Rosalind L., Wiesmüeller, Lisa, Wiegmans, Adrian P., Bain, Amanda, Lombard, Fanny J., Roberts, Tara L., Khanna, Kum Kum, Lavin, Martin F., Kim, Baek, Hamerlik, Petra, Johns, Terrance G., Coster, Mark J., Boyd, Andrew W. and Day, Bryan W. (2020). Simultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophore. Neuro-Oncology, 22 (2), 216-228. doi: 10.1093/neuonc/noz159
D’Souza, Rochelle C. J., Offenhäuser, Carolin, Straube, Jasmin, Baumgartner, Ulrich, Kordowski, Anja, Li, Yuchen, Stringer, Brett W., Alexander, Hamish, Lwin, Zarnie, Inglis, Po-Ling, Jeffree, Rosalind L., Johns, Terrance G., Boyd, Andrew W. and Day, Bryan W. (2020). Q-Cell glioblastoma resource: proteomics analysis reveals unique cell-states are maintained in 3D culture. Cells, 9 (2). doi: 10.3390/cells9020267
Brighi, Caterina, Reid, Lee, White, Alison L., Genovesi, Laura A., Kojic, Marija, Millar, Amanda, Bruce, Zara, Day, Bryan W., Rose, Stephen, Whittaker, Andrew K. and Puttick, Simon (2020). MR-guided focused ultrasound increases antibody delivery to nonenhancing high-grade glioma. Neuro-Oncology Advances, 2 (1) vdaa030, 1-12. doi: 10.1093/noajnl/vdaa030
Ebert, Lisa M., Yu, Wenbo, Gargett, Tessa, Toubia, John, Kollis, Paris M., Tea, Melinda N., Ebert, Brenton W., Bardy, Cedric, van den Hurk, Mark, Bonder, Claudine S., Manavis, Jim, Ensbey, Kathleen S., Oksdath Mansilla, Mariana, Scheer, Kaitlin G., Perrin, Sally L., Ormsby, Rebecca J., Poonnoose, Santosh, Koszyca, Barbara, Pitson, Stuart M., Day, Bryan W., Gomez, Guillermo A and Brown, Michael P (2020). Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy. Clinical and Translational Immunology, 9 (10) e1191. doi: 10.1002/cti2.1191
Brighi, Caterina, Reid, Lee, Genovesi, Laura A., Kojic, Marija, Millar, Amanda, Bruce, Zara, White, Alison L., Day, Bryan W., Rose, Stephen, Whittaker, Andrew K. and Puttick, Simon (2020). Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity. Theranostics, 10 (14), 6361-6371. doi: 10.7150/thno.46468
Müller Bark, Juliana, Kulasinghe, Arutha, Chua, Benjamin, Day, Bryan W. and Punyadeera, Chamindie (2020). Circulating biomarkers in patients with glioblastoma. British Journal of Cancer, 122 (3), 295-305. doi: 10.1038/s41416-019-0603-6
Abbassi, Ramzi H., Recasens, Ariadna, Indurthi, Dinesh C., Johns, Terrance G., Stringer, Brett W., Day, Bryan W. and Munoz, Lenka (2019). Lower Tubulin Expression in Glioblastoma Stem Cells Attenuates Efficacy of Microtubule-Targeting Agents. ACS Pharmacology and Translational Science, 2 (6), 402-413. doi: 10.1021/acsptsci.9b00045
Day, Bryan W., Lathia, Justin D., Bruce, Zara C., D’Souza, Rochelle C. J., Baumgartner, Ulrich, Ensbey, Kathleen S., Lim, Yi Chieh, Stringer, Brett W., Akgül, Seçkin, Offenhäuser, Carolin, Li, Yuchen, Jamieson, Paul R., Smith, Fiona M., Jurd, Courtney L. R., Robertson, Thomas, Inglis, Po-Ling, Lwin, Zarnie, Jeffree, Rosalind L., Johns, Terrance G., Bhat, Krishna P. L., Rich, Jeremy N., Campbell, Kevin P. and Boyd, Andrew W. (2019). The dystroglycan receptor maintains glioma stem cells in the vascular niche. Acta Neuropathologica, 138 (6), 1033-1052. doi: 10.1007/s00401-019-02069-x
Li, Yuchen, Song, Qingkun and Day, Bryan W. (2019). Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis. Acta Neuropathologica Communications, 7 (1) 123, 123. doi: 10.1186/s40478-019-0773-8
Lim, Yi Chieh, Quek, Hazel, Offenhäuser, Carolin, Fazry, Shazrul, Boyd, Andrew, Lavin, Martin, Roberts, Tara and Day, Bryan (2018). ATM inhibition prevents interleukin-6 from contributing to the proliferation of glioblastoma cells after ionizing radiation. Journal of Neuro-Oncology, 138 (3), 509-518. doi: 10.1007/s11060-018-2838-0
Betts, Joshua A., Moradi Marjaneh, Mahdi, Al-Ejeh, Fares, Lim, Yi Chieh, Shi, Wei, Sivakumaran, Haran, Tropee, Romain, Patch, Ann.-Marie, Clark, Michael B., Bartonicek, Nenad, Wiegmans, Adrian P., Hillman, Kristine M., Kaufmann, Susanne, Bain, Amanda L., Gloss, Brian S., Crawford, Joanna, Kazakoff, Stephen, Wani, Shivangi, Wen Shu W., Day, Bryan, Moller, Andreas, Cloonan, Nicole, Pearson,John, Brown, Melissa A., Mercer, Timothy R., Waddell, Nicola, Khanna, Kum Kum, Dray, Eloise, Dinger, Marcel E. ... French, Juliet D. (2017). Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage. American Journal of Human Genetics, 101 (2), 255-266. doi: 10.1016/j.ajhg.2017.07.007
Stringer, Brett W., Bunt, Jens, Day, Bryan W., Barry, Guy, Jamieson, Paul R., Ensbey, Kathleen S., Bruce, Zara C., Goasdoué, Kate, Vidal, Helene, Charmsaz, Sara, Smith, Fiona M., Cooper, Leanne T., Piper, Michael, Boyd, Andrew W. and Richards, Linda J. (2016). Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma. Oncotarget, 7 (20), 29306-12320. doi: 10.18632/oncotarget.8720
Grundy, Thomas James, De Leon, Ellen, Griffin, Kaitlyn Rose, Stringer, Brett William, Day, Bryan William, Fabry, Ben, Cooper-White, Justin and O'Neill, Geraldine Margaret (2016). Differential response of patient-derived primary glioblastoma cells to environmental stiffness. Scientific Reports, 6 (23353) 23353, 1-10. doi: 10.1038/srep23353
Puttick, Simon, Stringer, Brett W., Day, Bryan W., Bruce, Zara C., Ensbey, Kathleen S., Mardon, Karine, Cowin, Gary J., Thurecht, Kristofer J, Whittaker, Andrew K., Fay, Michael, Boyd, Andrew W. and Rose, Stephen (2015). EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging Study. Molecular Imaging, 14 (6), 385-395. doi: 10.2310/7290.2015.00008
Rundle-Thiele, Dayle, Day, Bryan, Stringer, Brett, Fay, Michael, Martin, Jennifer, Jeffree, Rosalind L., Thomas, Paul, Bell, Christopher, Salvado, Olivier, Gal, Yaniv, Coulthard, Alan, Crozier, Stuart and Rose, Stephen (2015). Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical method. Journal of Medical Radiation Sciences, 62 (2), 92-98. doi: 10.1002/jmrs.103
Day, B. W., Stringer, B. W. and Boyd, A. W. (2014). Eph receptors as therapeutic targets in glioblastoma. British Journal of Cancer, 111 (7), 1255-1261. doi: 10.1038/bjc.2014.73
Lim, Yi Chieh, Roberts, Tara L., Day, Bryan W., Stringer, Brett W., Kozlov, Sergei, Fazry, Shazrul, Bruce, Zara C., Ensbey, Kathleen S., Walker, David G., Boyd, Andrew W. and Lavin, Martin F. (2014). Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells. Molecular Oncology, 8 (8), 1603-1615. doi: 10.1016/j.molonc.2014.06.012
Al-Ejeh, Fares, Offenhäuser, Carolin, Lim, Yi Chieh, Stringer, Brett W., Day, Bryan W. and Boyd, Andrew W. (2014). Eph family co-expression patterns define unique clusters predictive of cancer phenotype. Growth Factors, 32 (6), 254-264. doi: 10.3109/08977194.2014.984807
Day, Bryan W., Stringer, Brett W., Wilson, John, Jeffree, Rosalind L., Jamieson, Paul R., Ensbey, Kathleen S., Bruce, Zara C., Inglis, Po, Allan, Suzanne, Winter, Craig, Tollesson, Gert, Campbell, Scott, Lucas, Peter, Findlay, Wendy, Kadrian, David, Johnson, David, Robertson, Thomas, Johns, Terrance G., Bartlett, Perry F., Osborne, Geoffrey W. and Boyd, Andrew W. (2013). Glioma surgical aspirate: a viable source of tumor tissue for experimental research. Cancers, 5 (2), 357-371. doi: 10.3390/cancers5020357
Day, Bryan W., Stringer, Brett W., Al-Ejeh, Fares, Ting, Michael J., Wilson, John, Ensbey, Kathleen S., Jamieson, Paul R., Bruce, Zara C., Lim, Yi Chieh, Offenhauser, Carolin, Charmsaz, Sara, Cooper, Leanne T., Ellacott, Jennifer K., Harding, Angus, Leveque, Lucie, Inglis, Po, Allan, Suzanne, Walker, David G., Lackmann, Martin, Osborne, Geoffrey, Khanna, Kum Kum, Reynolds, Brent A., Lickliter, Jason D. and Boyd, Andrew W. (2013). EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme. Cancer Cell, 23 (2), 238-248. doi: 10.1016/j.ccr.2013.01.007
Day, Bryan W., Stringer, Brett W., Spanevello, Mark D., Charmsaz, Sara, Jamieson, Paul R., Ensbey, Kathleen S., Carter, Jacinta C., Cox, Joanne M., Ellis, Vicky J., Brown, Christopher L., Walker, David G., Inglis, Po L., Allan, Suzanne, Reynolds, Brent A., Lickliter, Jason D. and Boyd, Andrew W. (2011). ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1. Neuro-Oncology, 13 (11), 1202-1212. doi: 10.1093/neuonc/nor119
Ting, Michael J., Day, Bryan W., Spanevello, Mark D. and Boyd, Andrew W. (2010). Activation of ephrin A proteins influences hematopoietic stem cell adhesion and trafficking patterns. Experimental Hematology, 38 (11), 1087-1098. doi: 10.1016/j.exphem.2010.07.007
McCarron, JK, Stringer, BW, Day, BW and Boyd, AW (2010). Ephrin expression and function in cancer. Future Oncology, 6 (1), 165-176. doi: 10.2217/FON.09.146
Day, B, To, C, Himanen, JP, Smith, FM, Nikolov, DB, Boyd, AW and Lackmann, M (2005). Three distinct molecular surfaces in ephrin-A5 are essential for a functional interaction with EphA3. Journal of Biological Chemistry, 280 (28), 26526-26532. doi: 10.1074/jbc.M504972200